Somite.ai
AI-based Platform to Produce Human Tissue for Cell-based Therapies
Startup A Health Tech & Life Sciences Est. 2023
๐ŸŒ WebsiteLinkedIn
Total Raised
$57.5M
A
Last Round
$47.5M
3 rounds
Investors
16
16 public
Team
7
11-50 employees
Confidence
81/100
News
8
articles
About
Somite.ai is aiming to become the OpenAI of stem cell biology, developing AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies. Somite's AI platform, AlphaStem, fuels a virtuous cycle as it enables new cell therapies, generating massive data that further improve the platform, empowering even faster therapy creation with broader applications. The company's pipeline includes the promising SMT-M01 program for Duchenne muscular dystrophy (DMD) and the SMT-B01 program for metabolic disorders.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Core Technology
Artificial Intelligence
Target Customer
Healthcare & Life SciencesLife SciencesBiotechnology
Business Model
B2C
Tags
artificial-intelligencecell-therapystem-cells
Funding & Events
Sep 2024
Seed $4.7M
Astellas Venture Management, Montage Ventures
May 2025
A Round $47.5M
Khosla Ventures (Lead), Fusion Fund, Ajinomoto, Martin Chavez, TechAviv, Pitango HealthTech, Scifi VC, Chan Zuckerberg Initiative, Harpoon Ventures
Apr 2024
Pre-Seed $5.3M
TechAviv Founder Partners (Lead), Next Coast Ventures, Texas Venture Partners, Lerer Hippeau Ventures, Trust Ventures
News (8)
Jun 9, 2025 ยท www.themarker.com
growth-positive
ื—ื‘ืจืช Somite.ai ื‘ื”ื•ื‘ืœืช ืžื“ืขื ื™ื ื™ืฉืจืืœื™ื ืžื ืกื” ืœืคืชื•ืจ ื‘ืขื™ื” ืฉืžืขืกื™ืงื” ื—ื•ืงืจื™ื ื›ื‘ืจ ืขืฉื•ืจื™ื: ืื™ืš ืœื’ืจื•ื ืœืชื ื’ื–ืข ืœื”ืคื•ืš ื‘ื“ื™ื•ืง ืœืžื” ืฉืฆืจื™ืš โ€” ื•ื‘ืงื ื” ืžื™ื“ื” ืชืขืฉื™ื™ืชื™. ืื ืชืฆืœื™ื—, ืชืื™ื ื‘ื™ื•ืœื•ื’ื™ื™ื ื™ื•ื›ืœื• ืœื”ื—ืœื™ืฃ ืชืจื•ืคื•ืช โ€” ื•ืœืฉืงื ืชืคืงื•ื“ื™ื ืฉืื‘ื“ื•
May 13, 2025 ยท www.calcalistech.com
growth-positive
Somite AI secures $47.5 million Series A to expand AI platform for cell therapy | CTech
InvestmentManagement Changes
May 13, 2025 ยท en.globes.co.il
growth-positive
Somite AI is building DeltaStem, a platform and foundation model designed to revolutionize the production of human cells.
Investment
Sep 10, 2024 ยท www.calcalistech.com
growth-positive
Before joining Somite.ai, Kivity served as Chief of Staff and first U.S. employee at 4M Analytics. He joins the company after completing over 250 days of reserve duty in the Iron Swords war as a Deputy Battalion Commander in Gaza.
Management ChangesInvestment
Sep 3, 2024 ยท www.calcalistech.com
growth-positive
Somite.ai takes pre-seed to $10M as it eyes to become โ€˜the OpenAI of stem cell biologyโ€™ | CTech
Investment
Apr 16, 2024 ยท www.calcalistech.com
growth-positive
Somite raises $5.3 million to incorporate AI in stem cell therapy | CTech
InvestmentPartners
Apr 9, 2024 ยท www.forbes.com
growth-positive
Forbes: This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Market
InvestmentExpand
Feb 29, 2024 ยท en.globes.co.il
growth-positive
Together with Harvard and MIT scientists, Micha Breakstone founded Somite.ai, which combines stem cell and AI techniques to develop new therapies.
Investment
Details
Product Stage
R&D
Employees
11-50
Exact Count
48
Founded
2023
Locations
Israel
240 Longwood Ave, Boston, MA 02115, USA
Links
Website
www.somite.ai
LinkedIn
Profile
Admin
Last Update
Sep 17, 2025
Verified by
Matan Eblagon
Claimed
Yes
Missing
sector, video or image, markets, not claimed
Team (7)
Micha Breakstone
Co-founder & CEO
Founder
Olivier Pourquie
Co-founder
Founder
Jay Shendure
Co-founder
Founder
Allon Klein
Co-founder
Founder
Cliff Tabin
Co-founder
Founder
Jonathan Rosenfeld
Co-founder & CTO
Founder
Shai Kivity
VP of Strategy & Ops
Internal
Created by
Matan Eblagon (matane@sncentral.org)
Created
2024-09-03T00:00:00.000Z
Finder ยท Somite.ai ยท 2026